Healthcare Company Announces Record-breaking Sales of Its Eyecare Product
For NovaBay, this success could translate into a positive outlook for its stock in 2024 by demonstrating strong revenue growth.
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) stands out, particularly in the realm of eyecare. April 2024 marked a significant milestone for the company, as it announced record-breaking sales of its Avenova-branded products through Amazon.com, its largest sales channel. This achievement is not just a testament to the company's strategic direction but also signals a growing consumer demand for high-quality eyecare solutions. $NovaBay Pharmaceuticals(NBY.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
